Inventage Lab will participate in the Asia Bio Partnering Forum 2026, taking place September 1–2, 2026 at Marina Bay Sands in Singapore.
Hosted by Informa Connect (EBD Group), the Asia Bio Partnering Forum is one of Asia's leading biotech partnering events, bringing together 650+ senior leaders from the biotech, pharma, and investment sectors across more than 35 countries. Over 2,500 one-to-one meetings are conducted through the partneringONE platform, making the forum a key venue for cross-border dealmaking in the Asia-Pacific region.
Inventage Lab is a clinical-stage biotech developing next-generation drug delivery platforms based on its proprietary microfluidic technology. Its platforms include DrugFluidic® for long-acting injectables (LAI) of small molecules and peptides, BioFluidic™ for subcutaneous formulation optimization of antibody and protein therapeutics, and GeneFluidic®, an LNP platform for nucleic acid-based therapeutics. Each platform is designed to overcome the limitations of conventional formulations and enhance the value of global partners' pipelines.
At this year's forum, Inventage Lab will focus on one-to-one partnering meetings, actively exploring co-development, licensing, and CDMO partnership opportunities across a range of indications including obesity and metabolic disease, CNS, and oncology.
Meetings are available both on-site in Singapore (September 1–2) and via digital partnering (September 8–9), and can be requested through the partneringONE platform. We welcome meeting requests from pharmaceutical and biotech companies interested in global partnering.
